| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 12 |
| 1 | FINASTERIDE | 7 |
| 2 | SOMATROPIN | 6 |
| 3 | INFLIXIMAB | 5 |
| 4 | ACETAMINOPHEN | 4 |
| 5 | AMLODIPINE BESYLATE | 4 |
| 6 | AZATHIOPRINE | 4 |
| 7 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 4 |
| 8 | EMICIZUMAB | 4 |
| 9 | ERGOCALCIFEROL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARNICA MONTANA, HYPERICUM PERFORATUM, LEDUM PALUSTRE, MORBILLINUM, NATRUM MURIATICUM, SILICEA, SULPHUR IODATUM, THUJA OCCIDENTALIS, URTICA URENS | 1 | 0.0047 |
| 1 | MECASERMIN | 3 | 0.0037 |
| 2 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 3 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 4 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 5 | NITISINONE | 1 | 0.0010 |
| 6 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| 7 | ETEPLIRSEN | 2 | 0.0008 |
| 8 | DEFLAZACORT | 2 | 0.0008 |
| 9 | IDURSULFASE | 3 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 1 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 2 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 5 | 0.0004 |
| 4 | Antisense Oligonucleotide [EPC] | 3 | 0.0003 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 9 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |